Answers are grounded in this paper and cite their sources.
A woman spends more than a third of her life in a state of deficiency of female sex hormones. According to the WHO, in most countries of the world, the life expectancy of women after 50 years ranges from 27 to 32 years. The number of women entering menopause is increasing every year. In 1990, 467 million women were in the postmenopausal period, by 2030 it will reach 1.2 billion. Menopause, not being a disease itself, leads to disruption of the endocrine balance in a woman’s body, causing not only «classic» problems in a woman’s life (vasomotor symptoms, disorders of psychological health, urogenital disorders, osteoporosis, cardiovascular diseases), but the woman’s appearance changes — the dermatological status of the patient of a more terrible age group changes. This manifests itself in the form of a loss of collagen, elastin, a change in fibroblast function, vascularization and an increase in the enzymatic activity of matrix metalloproteinases, which leads to cellular and extracellular degradation, which in turn — to dryness, wrinkles, atrophy, impaired wound healing, a decrease in antioxidant capacity, a decrease in attractiveness and psychological health, as well as an increased perception of aging in your body. Menopausal hormone therapy is the «gold» standard of patient management in menopausal and postmenopausal women, however, its role in the preservation of the epidermis and dermis is still unclear. In the modern literature, the positive effects of MHT on the patient’s skin have been noted, however, there are not enough randomized studies to draw unambiguous conclusions. This review summarizes the current understanding of the structural, functional, and biochemical changes accompanying skin aging under conditions of a deficiency in the protective function of estrogens.
No takes yet. Share an insight, caveat, or question.
Andreeva et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: